Future of Health Analytics | Deloitte US has been added to your bookmarks.
The future of health analytics
Unlocking clinical and business value
The recent explosion of data volume, consolidation within the industry, and government requirements have created a “perfect storm” for analytics in the health care industry. What potential does analytics hold for organizations?
Using analytics to improve value
Each new wave of technological innovation has produced an exponential growth of data volume for health care organizations. Increase in data volume has led to an increase in the need to capture and process it. Along with the lack of a streamlined process, consolidation within the health care industry has exacerbated access and availability problems. Government compliance and coding requirements have contributed to make this a “perfect storm” for analytics in the health care industry.
Furthermore, organizations view problems around widespread implementation and adoption as insurmountable obstacles. Fortunately, industry stakeholders are starting to see solutions and advancements that may produce a sea-change.
Unifying the relationship between physicians and patients
More than 40 senior executives representing health care providers, payers, innovators, life sciences organizations, and government convened at the MIT Media Lab in Boston, MA for a dialogue on the future of health analytics. They discussed challenges, opportunities, and actionable approaches to using health analytics and health data to improve clinical outcomes and business value.
The primary challenges and opportunities may be grouped into the following areas:
- The science and art of health analytics
- Barriers to analytics adoption
- Disruptive developments
- The empowered patient
Download the PDF to discover how making data actionable can help unify the relationship between physicians and patients.
When we look for near term low hanging fruit to improve the cost and quality of care, perhaps instead of only new drugs, we need software and algorithms for intervening with patients to better utilize the pharmacopeia we have. The potential for disruption is when behavioral interventions can garner measurably competitive incentive value with devices, procedures, and drugs.
Brigham Hyde, Chief Data Officer, Decision Resources Group